Business
-
Jun 06 2020Novartis phase IIIb ARGON study meets primary endpoint in a comparison of Enerzair Breezhaler vs free combo of two existing inhaled treatments in uncontrolled asthma
Novartis announced that full results from the phase IIIb ARGON…
Read more -
Jun 06 2020WHO welcomes crucial new funding for vaccines
WHO welcomes funding commitments made at the Global Vaccine Summit,…
Read more -
Jun 06 2020AbbVie announces positive results from phase 3 study of Rinvoq in patients with rheumatoid arthritis
AbbVie, a research-based global biopharmaceutical company, announced new long-term results…
Read more -
Jun 06 2020Healthcare can be India’s next IT sector – Kiran Mazumdar-Shaw
Top industry captains are batting for livelihoods, as India readies…
Read more -
Jun 06 2020US FDA approves Recarbrio to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
The US Food and Drug Administration (FDA) approved Recarbrio (a…
Read more -
May 26 2020Hydroxychloroquine (HCQ) is a prescription medicine & is not to be used without medical advice. Do not test Hydroxychloroquine (HCQ) without medical guide – Health Ministry
State governments in India may soon release campaigns in the…
Read more -
May 15 2020Govt rolls out packages for farmers & migrant workers. Govt says measures will empower the poor, migrant workers and farmers by ensuring credit facilities, food and social security for them.
Finance Minister Nirmala Sitharaman on Thursday said the second tranche…
Read more -
May 14 2020Swiss healthcare company Roche gets through coronavirus antibody test by Public Health England
The first coronavirus antibody test that could help ease lockdown…
Read more -
May 14 2020It is hard to imagine a more difficult situation, the catastrophe of COVID-19 and the disaster of a category five cyclone all wrapped into one – United Nations
As the coronavirus pandemic has halted the global travel industry,…
Read more -
May 06 2020Vaxxel buys Transgene’s DuckCelt-T17 cell line to develop industrial-scale vaccines against respiratory viruses
Vaxxel SAS, a French start-up, developing vaccines against respiratory viral…
Read more
